We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SENEB:NASDAQSeneca Foods Corp. Analysis

Data as of 2026-04-30 - not real-time

$135.00

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Seneca Foods is trading around $135, comfortably above its 200‑day SMA of $119 but below the 20‑day ($146.8) and 50‑day ($141.5) averages, indicating short‑term weakness despite a longer‑term bullish trend. The stock sits just above the calculated support of $131.45 and faces a sizable resistance near $165, while a 14‑day RSI of 37 suggests modest oversold conditions. Technical momentum is mixed, with a bearish MACD histogram and line, yet volume is on the rise, supporting the recent 38.9% three‑month rally highlighted in the news. Fundamentally, the company shows modest revenue growth (1.1%), low gross margins (~12.6%), but solid profitability (PE ≈ 10.4, PB ≈ 1.29) and a healthy operating cash flow of $206 M. The DCF‑derived fair value of $276.7 implies the market is pricing the stock at roughly half of intrinsic worth, though a net debt position of $260 M and a max drawdown of 20% add downside pressure. Overall, the defensive consumer sector backdrop provides stability, but high 30‑day volatility (≈60%) and limited growth keep the risk profile elevated.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near immediate support at $131.45
  • Bearish MACD signal despite rising volume
  • Elevated 30‑day volatility (~60%)

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Significant undervaluation versus DCF fair value
  • Defensive consumer‑staples sector offering stability
  • Improving volume trend indicating renewed buying interest

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Intrinsic value gap (~$140 upside potential)
  • Stable cash generation and reasonable ROE (~13.6%)
  • Low market beta reducing systematic risk over time

Key Metrics & Analysis

Financial Health

Revenue Growth1.10%
Profit Margin5.58%
P/E Ratio10.4
ROE13.57%
ROA6.67%
Debt/Equity41.21
P/B Ratio1.3
Op. Cash Flow$206.0M
Free Cash Flow$151.8M

Technical Analysis

TrendBullish
RSI37.2
Support$131.45
Resistance$164.98
MA 20$146.77
MA 50$141.50
MA 200$119.36
MACDBearish
VolumeIncreasing
Fear & Greed Index88.27

Valuation

Fair Value$276.66
GradeUndervalued
TypeValue

Risk Assessment

Beta-0.01
Volatility60.02%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.